HEM PharmaHEM파마
376270 · KOSDAQ · ₩376270 · HEM파마
₩26,200▲ ₩50 (0.19%)End-of-day · Oct 30, 2026 · End-of-day prices.
Filings
- Amended: Major sales or supply contract[기재정정]단일판매ㆍ공급계약체결Sep 9, 2026Open on DART
- Amended: Major sales or supply contract[기재정정]단일판매ㆍ공급계약체결Sep 4, 2026Open on DART
- Half-year report (Jun 2026)반기보고서 (2026.06)Aug 21, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 20, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Aug 20, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최Aug 19, 2026Open on DART
- Securities Issuance Results (Voluntary Disclosure)증권발행결과(자율공시)Aug 14, 2026Open on DART
- Convertible bond issue decision주요사항보고서(전환사채권발행결정)Aug 6, 2026Open on DART
- Amended: Annual report (Dec 2025)[기재정정]사업보고서 (2025.12)Jul 29, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jul 13, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Jul 13, 2026Open on DART
- Major sales or supply contract단일판매ㆍ공급계약체결Jun 24, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jun 22, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Jun 22, 2026Open on DART
- Acquisition of shares in another company타법인주식및출자증권취득결정Jun 19, 2026Open on DART
- New Facility Investment, etc.신규시설투자등Jun 19, 2026Open on DART
- Amended: Convertible bond issue decision[기재정정]주요사항보고서(전환사채권발행결정)Jun 19, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최May 22, 2026Open on DART
- Major sales or supply contract단일판매ㆍ공급계약체결May 14, 2026Open on DART
- Quarterly report (Mar 2026)분기보고서 (2026.03)May 11, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최May 8, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Apr 6, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Apr 6, 2026Open on DART
- Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Mar 27, 2026Open on DART
- Amended: Company split decision[기재정정]주요사항보고서(회사분할결정)Mar 27, 2026Open on DART
- Annual general meeting results정기주주총회결과Mar 26, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최Mar 25, 2026Open on DART
- Audit report submitted감사보고서제출Mar 18, 2026Open on DART
- Annual report (Dec 2025)사업보고서 (2025.12)Mar 18, 2026Open on DART
- [Amended] Reference Document for Proxy Solicitation of Voting Rights[기재정정]의결권대리행사권유참고서류Mar 13, 2026Open on DART
- Amended: Notice of shareholders' meeting[기재정정]주주총회소집공고Mar 13, 2026Open on DART
- Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Mar 11, 2026Open on DART
- Notice of shareholders' meeting주주총회소집공고Mar 11, 2026Open on DART
- Amended: Company split decision[기재정정]주요사항보고서(회사분할결정)Mar 6, 2026Open on DART
- Company split decision주요사항보고서(회사분할결정)Mar 6, 2026Open on DART
- Shareholders' meeting called주주총회소집결의Mar 5, 2026Open on DART
- Major sales or supply contract단일판매ㆍ공급계약체결Feb 24, 2026Open on DART
- Occurrence of Derivatives Trading Loss파생상품거래손실발생Feb 20, 2026Open on DART
- Change in Revenue or Profit/Loss Structure of 30% or More (15% or More for Large Companies)매출액또는손익구조30%(대규모법인은15%)이상변동Feb 20, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최Jan 26, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최Jan 22, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최Jan 20, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jan 7, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Dec 26, 2025Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Dec 26, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Dec 19, 2025Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Dec 19, 2025Open on DART
- Other Market Notice (Abbreviated and English Names) (Korean Abbreviated Name)기타시장안내(약명및영문명) (한글약명)Dec 12, 2025Open on DART
- Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 12, 2025Open on DART
- 5%+ holding report주식등의대량보유상황보고서(약식)Dec 10, 2025Open on DART
Titles in Korean until English translations are added.
Also known as: HEM Pharma / HEM파마 / 376270 / KRX:376270
Source: KRX statistical information